# cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine

> **NIH NIH N01** · INTERNATIONAL AIDS VACCINE INITIATIVE · 2022 · $3,974,723

## Abstract

This contract program will provide NIAID with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products for HIV and other candidate agents. This contract will provide the support and services needed for all stages of process and product development, small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submissions for Phase I, II, and III clinical testing. These capabilities will allow NIAID to rapidly and efficiently address development and production gaps.

## Key facts

- **NIH application ID:** 10697059
- **Project number:** 75N93022D00005-0-759302200001-1
- **Recipient organization:** INTERNATIONAL AIDS VACCINE INITIATIVE
- **Principal Investigator:** THOMAS HASSELL
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $3,974,723
- **Award type:** —
- **Project period:** 2021-12-01 → 2022-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10697059

## Citation

> US National Institutes of Health, RePORTER application 10697059, cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine (75N93022D00005-0-759302200001-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10697059. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*